Status:
RECRUITING
Respiratory Function, Physical Activity and Fatigue in SLE
Lead Sponsor:
Melis Usul
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
18-65 years
Brief Summary
Increasing awareness of possible pulmonary involvement in patients with systemic lupus erythematosus (SLE) will enable earlier diagnosis of the disease and minimize damage accumulation. According to o...
Detailed Description
Systemic lupus erythematosus (SLE) is a chronic, inflammatory, autoimmune disease characterized by multisystem involvement. SLE can affect any organ or tissue, including the skin, joints, kidneys, cen...
Eligibility Criteria
Inclusion
- Patients who have been followed with a diagnosis of systemic lupus erythematosus for at least 1 year
- Able to ambulate independently
- No cognitive or mental impairment
- Willing to participate in the study
Exclusion
- Presence of major musculoskeletal disease affecting the lower extremities
- Presence of severe disease affecting the cardiovascular system
- Being pregnant
- Smoking
- Having a diagnosis of restrictive/interstitial lung disease due to the underlying condition
Key Trial Info
Start Date :
September 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07193745
Start Date
September 5 2025
End Date
October 30 2025
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University-Cerrahpasa
Istanbul, Fatih, Turkey (Türkiye)